Oak Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Oak Asset Management's PFE Position: Q3 2025 in Review
Oak Asset Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 10,602 shares — an estimated $257K sold.
Oak Asset Management first reported a position in PFE in Q4 2017 and held it in 23 quarters. The position peaked at $955K in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Oak Asset Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Oak Asset Management sold 10,602 Pfizer shares in Q3 2025, an estimated $257K.
- Oak Asset Management first reported a position in Pfizer in Q4 2017 and held it in 23 quarters.
- Oak Asset Management's Pfizer position peaked at $955K in Q4 2021.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Oak Asset Management's 13F filing for Q3 2025, filed 20 Oct 2025.